Eugene Braunwald, Influential Cardiologist, Dies at 96
Eugene Braunwald, a pioneering cardiologist whose research fundamentally changed the treatment of heart disease, passed away on Wednesday in Newton, Massachusetts, at the age of 96. His daughter, Jill Braunwald Porter, confirmed his death at a hospital. He had resided in Weston, Massachusetts.
Regarded as one of the most significant figures in cardiology, Dr. Braunwald played a key role in turning heart disease from a life-threatening condition into one that can often be managed with appropriate medications, procedures, and careful observation. His work established cardiology as a scientific discipline rooted in physiology, clinical trials, and evidence-based practices.
Dr. Braunwald’s research changed medical understanding of heart attacks, heart failure, and coronary artery disease, leading to life-saving therapies that significantly reduced heart workload and blood pressure, as well as procedures that reopened blocked arteries.
Influential Textbook and Lasting Impact
Since its initial edition in 1980, “Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine” has been a foundational resource in the field, often simply called “Braunwald” by many practitioners—a shorthand for a continuously expanding knowledge base.
Dr. Thomas H. Lee, who chronicled Dr. Braunwald’s impact in a 2013 biography, remarked that Braunwald devoted his life to addressing crucial questions that aimed to improve health outcomes for patients with cardiovascular ailments.
His contributions were both theoretical and practical, redefining heart attacks as processes that could be mitigated. He introduced the concept that decreasing the heart’s workload after an attack could limit damage, shifting focus from merely treating symptoms to using medications that alter the disease’s trajectory.
In the 1960s, the prevailing belief among many doctors was that heart attacks were sudden and irreversible. However, in 1971, Dr. Braunwald and his colleagues at UC San Diego published work revealing that heart muscle damage often progressed over hours, paving the way for quicker restoration of blood flow through various treatments.
Pioneering Research and Clinical Trials
Dr. Braunwald was also instrumental in integrating rigorous randomized clinical trials into cardiology, which further modernized the field. Dr. Douglas Vaughan, who worked with Braunwald in the late 1980s, said in a 2007 interview that every cardiologist must acknowledge the profound impact of Braunwald’s research and insights related to acute myocardial infarction.
Throughout his lengthy career, particularly during his decades associated with Harvard, Dr. Braunwald authored over 1,000 scientific papers. His studies spanned basic physiology to extensive clinical trials involving thousands of patients.
His influence extended beyond his research as he served as a mentor to many cardiologists who went on to lead in academia and clinical practice. However, his tenure also included involvement in a high-profile research scandal when a young researcher under his supervision was found to have falsified data. While Dr. Braunwald acted by terminating the fellowship, some criticized him for not notifying funding agencies.
Early Life and Education
Eugene Braunwald was born on August 15, 1929, in Vienna to a Jewish family. His childhood was marred by the rise of Nazism, and after Austria was annexed in 1938, his family, guided by his mother, made a dangerous escape to England before ultimately settling in Brooklyn.
Encouraged by his mother to pursue medicine, he graduated from New York University at just 19 and went on to NYU’s School of Medicine, where he finished at the top of his class in 1952. He completed his residency at Mount Sinai Hospital in New York, later working under Nobel laureate André Cournand.
In 1955, Dr. Braunwald joined the National Heart Institute, which eventually became the National Heart, Lung, and Blood Institute. There, he researched heart failure and coronary artery disease, later becoming one of its youngest clinical directors.
Significant Clinical Trials and Contributions
Dr. Braunwald’s work clarified how the heart responds to various stresses, ultimately forming the basis for modern diagnostic and treatment methods in cardiology. After moving to UC San Diego in 1968, he helped establish a medicine department before returning to Harvard Medical School in 1972, where he led major clinical trials that showcased the effectiveness of beta blockers and ACE inhibitors.
His research also advanced understanding of unstable angina. In 1952, he married Dr. Nina Starr, a cardiac surgeon known for being the first woman to successfully implant an artificial heart valve. She passed away in 1992, and two years later, he married Elaine Smith, a former COO at Brigham and Women’s Hospital.
Dr. Braunwald is survived by his wife Elaine, his daughter Jill, as well as two other daughters, Karen Braunwald and Allison Goldfine; seven grandchildren; and four great-grandchildren.
Continued Engagement in Cardiovascular Research
Even into the 21st century, Dr. Braunwald remained significantly involved in research, mentoring younger physicians, and contributing to clinical trials. Notably, in 2014, he led a study that identified an alternative cholesterol-lowering medication that could protect against heart attacks and strokes, reinforcing the importance of cholesterol management.
In his characteristic manner, he expressed that people could stop questioning the benefits of cholesterol reduction, saying, “People can stop yapping.”
